NCT02903160 2024-02-07Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)Icahn School of Medicine at Mount SinaiPhase 2 Completed40 enrolled 18 charts